Rimm Alfred A, Katayama Alyce C, Diaz Mireya, Katayama K Paul
Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
J Assist Reprod Genet. 2004 Dec;21(12):437-43. doi: 10.1007/s10815-004-8760-8.
To estimate the risk of major malformations in IVF and ICSI infants.
Forty-four studies published in English since 1990 where the major malformation rate for IVF or ICSI cases was compared to an appropriate control group were reviewed. Nineteen studies met all selection criteria. In addition, a quality score was developed to assess each study based on sample size, timing of diagnosis, appropriateness of control group and other factors.
In 19 studies, the major malformation rates ranged from 0-9.5% for IVF; 1.1-9.7 for ICSI; and 0-6.9% in the control groups. When ICSI was compared to IVF, and multiple births compared to singleton, there were no statistically significant differences. When data from 16 studies involving 28,524 IVF infants and 2,520,988 spontaneously conceived controls and 7 studies involving 7234 ICSI infants and 978,078 controls were pooled, we found an overall odds ratio for the 19 studies of 1.29 (95% CI 1.01-1.67).
The overall odds ratio of 1.29 was statistically significant at the 5% level. These results may be useful for counseling ART patients and properly designing the consent forms used for ART procedures. It is not clear whether this risk is due to the procedures used in ART. We found that some of these studies have design flaws. All of them lacked an appropriate control group, i.e. infertile patients conceiving spontaneously. These flaws may create biases that would in almost all instances increase the risk of major malformations in the study group. Further research with better designed studies will likely result in a better estimate of the risk of major malformations associated with IVF and ICSI.
评估体外受精(IVF)和卵胞浆内单精子注射(ICSI)婴儿发生严重畸形的风险。
回顾了自1990年以来以英文发表的44项研究,这些研究比较了IVF或ICSI病例的严重畸形率与适当的对照组。19项研究符合所有选择标准。此外,还制定了一个质量评分,根据样本量、诊断时间、对照组的适当性和其他因素对每项研究进行评估。
在19项研究中,IVF的严重畸形率为0 - 9.5%;ICSI为1.1 - 9.7%;对照组为0 - 6.9%。将ICSI与IVF进行比较,以及将多胎妊娠与单胎妊娠进行比较时,均无统计学上的显著差异。当汇总16项涉及28524例IVF婴儿和2520988例自然受孕对照的研究数据,以及7项涉及7234例ICSI婴儿和978078例对照的研究数据时,我们发现这19项研究的总体优势比为1.29(95%可信区间1.01 - 1.67)。
总体优势比1.29在5%水平上具有统计学显著性。这些结果可能有助于为接受辅助生殖技术(ART)的患者提供咨询,并合理设计ART程序中使用的知情同意书。目前尚不清楚这种风险是否归因于ART所使用的程序。我们发现其中一些研究存在设计缺陷。所有这些研究都缺乏适当的对照组,即自然受孕的不孕患者。这些缺陷可能会产生偏差,几乎在所有情况下都会增加研究组中严重畸形的风险。采用设计更优的研究进行进一步研究,可能会对与IVF和ICSI相关的严重畸形风险做出更好的评估。